FEATURED NEWS

• HDA To Convene Rx Supply Chain Professionals as Industry Closes in on Drug Supply Chain Security Act Implementation Deadline

  September 28, 2022

  The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar, providing an opportunity for supply chain professionals to discuss Drug Supply Chain Security Act (DSCSA) implementation.

• HDA Announces Chad Gielen and Kirk Kaminsky To Lead Board of Directors

  September 15, 2022

  The Healthcare Distribution Alliance (HDA) today announced the election of Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., as Chairman of the HDA Board of Directors. Kirk Kaminsky, President, McKesson U.S. Pharmaceutical, will serve as Vice Chairman.

• HDA Statement on FDA's Proposed National Standards for Licensure of Distributors and 3PLs

  September 7, 2022

  The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).

• HDA Statement on U.S. District Court Ruling in Huntington and Cabell County, West Virginia

  July 7, 2022

  The Healthcare Distribution Alliance released the following statement on the ruling by the U.S. District Court for the Southern District of West Virginia regarding the litigation in Huntington and Cabell County.

• Greg Drew, RPh, of Value Drug Honored With 2022 Nexus Award for Lifetime Achievement

  June 7, 2022

  The HDA Research Foundation honors Greg Drew, RPh, President of Value Drug Company, with the 2022 Nexus Award for Lifetime Achievement. The Nexus Award, the healthcare distribution industry’s highest individual recognition, was presented last night at the 2022 Business and Leadership Conference in Orlando, Fla.